'[3H]quipazine' degradation products label 5-HT uptake sites.
Schmidt
A W
AW
Department of Neurology, Stanford University Medical Center, CA 94305.
Hurt
S D
SD
Peroutka
S J
SJ
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D066298:In Vitro Techniques; D017374:Paroxetine; D010880:Piperidines; D011804:Quinolines / Q000378:metabolism*; D011814:Quipazine / Q000378:metabolism*; D011869:Radioligand Assay; D051381:Rats; D011985:Receptors, Serotonin / Q000378:metabolism*
D010880:Piperidines; D011804:Quinolines; D011985:Receptors, Serotonin; D017374:Paroxetine; D011814:Quipazine